All news Archives - Page 8 of 12

IBA Launches Versatile High-Energy New Cyclotron

IBA Launches Versatile High-Energy New Cyclotron Last June, IBA unveiled its new Cyclone® IKON. 35 years of experience and innovation concentrated in the new versatile, high-energy cyclotron for enhanced availability of theranostic radiopharmaceuticals and reduced radiopharmacy footprint. Cyclone® IKON offers the largest energy spectrum for PET and SPECT isotopes from...

Alexandra Schiettekatte In Other news

Online conference, HealthTech For Patients

Online Conference European healthtech experts meet to reaffirm the importance of health data to accelerate the development of patient care Paris, 16 june 2021 – HealthTech For Patients, the European conference on healthtech that takes into consideration the role of patients took place on 7 June in a digital...

Marine Divincenzo In BioWin news

The 34th call for collaborative R&I projects is now open!

Launching of the 34th call for collaborative R&I projects with a spotlight on the digitalisation of biomanufacturing! Do you have an innovative project idea and are you looking for partners to make it concrete? Your project is part of one of the strategic themes supported by the cluster, i.e: •...

Alexandra Schiettekatte In BioWin news

15 years of innovation … and ambitions for tomorrow!

Take a look at the retrospective in a few key figures: The Walloon Competitiveness Clusters play a central role in the transformation of Walloon industry. By bringing together private industrial players (small, medium and large companies), universities, research and training centers as well as public authorities around a common objective,...

Alexandra Schiettekatte In BioWin news

Industry 4.0 for biomanufacturing: discover the webinar replay of April 29, 2021

Digitization has a huge influence on our economy and society. In the industrial sector, we are talking about the fourth industrial revolution, industry 4.0 or the industry of the future. Today it is at the heart of the concerns of companies but also of governments for which the reindustrialization of...

Alexandra Schiettekatte In All news, BioWin news

MAGIA2market: You are a Medtech company? Tell us about your international needs !

MAGIA2market: You are a Medtech company? Tell us about your international needs ! For both the US, China and Japan, we have begun to collect profiles of companies interested in interacting with our foreign counterpart communities. The intention is to create dossiers to be submitted to the various international MedTech...

Elisa Wolf In All news, Member news

HealthTech For Care and EIT Health announce the opening of applications for European companies

3rd edition of HealthTech Innovation Days (4 & 5 October 2021) HealthTech For Care and EIT Health announce the opening of applications for European companies Paris, France, April 8, 2021 - HealthTech Innovation Days (HTID®) has become the reference event for European innovative healthcare companies that want to accelerate their...

Elisa Wolf In All news, Member news

Graftys Announces New Manufacturing & Logistic Site in Liège (Belgium)

Jumet (Belgium), March 30, 2021 – GRAFTYS SA ("Graftys"), a global leader in resorbable bone cements, announces today the opening of its new preparation and logistic site in Liège (Belgium). Continuously strengthening its manufacturing capability and reinforcing its logistic services to improve the quality of its products and the performance...

Elisa Wolf In All news, Member news

Orgenesis Enters into Collaboration Agreement with the Bambino Gesù Children’s Hospital in Rome to Establish Point of Care Cell and Gene Therapy Center

GERMANTOWN, Md., March 29, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies, announces that it has entered a collaboration with the Bambino Gesù Children's Hospital in Rome to establish a Point of Care Cell Therapy center...

Elisa Wolf In Member news

CyanVac selects Exothera for the development and GMP manufacturing of its COVID-19 intranasal vaccine candidate for phase III clinical trial in Europe and the US

Athens, Georgia, USA – March 24, 2021 – CyanVac LLC, a vaccine company, announced today that they have selected Exothera S.A., a full-service Contract Development and Manufacturing Organization (CDMO), for the development and manufacturing of their COVID-19 intranasal vaccine based on a proprietary parainfluenza virus 5 (PIV5) vector. Exothera will be...